Aroflo Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Contraindications Special Precautions Use In Pregnancy & Lactation Side Effects Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Per 25 mcg/125 mcg inhaler Salmeterol xinafoate 25 mcg, fluticasone propionate 125 mcg. Per 25 mcg/250 mcg inhaler Salmeterol xinafoate 25 mcg, fluticasone propionate 250 mcg

Indications/Uses

Regular treatment of asthma in patients not adequately controlled w/ inhaled corticosteroids & 'as needed' inhaled short-acting β₂-agonist; in patients already adequately controlled on both inhaled corticosteroids & long-acting β₂-agonist.

Click to view Aroflo detailed prescribing information

Dosage/Direction for Use

Adult & adolescent ≥12 yr 2 puffs bd.

Click to view Aroflo detailed prescribing information

Contraindications

Hypersensitivity.

Click to view Aroflo detailed prescribing information

Special Precautions

Should not be used to treat acute asthma. Avoid abrupt discontinuation. Patients w/ pulmonary TB, severe CV disorders, heart rhythm abnormalities, DM, thyrotoxicosis, uncorrected hypokalemia & predisposed to low levels of serum K. Pregnancy & lactation.

Click to view Aroflo detailed prescribing information

Use In Pregnancy & Lactation

Click to view Aroflo detailed prescribing information

Adverse Reactions

Tremor, palpitations, headache; cardiac arrythmia, hypersensitivity reactions eg, rash, oedema, angioedema; oropharyngeal irritation; hoarseness, candidiasis; adrenal suppression, growth retardation, decreased bone mineral density.

Drug Interactions

Nonselective & selective β-blockers. CYP3A4 inhibitors (eg, ketoconazole, ritonavir).

Click to view Aroflo detailed prescribing information

Caution For Usage

For caution against possible variation of physical aspect of medicine... Click to view Aroflo detailed prescribing information

Storage

View Aroflo storage conditions for details to ensure optimal shelf-life.

Description

View Aroflo description for details of the chemical structure and excipients (inactive components).

Action

View Aroflo mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Antiasthmatic & COPD Preparations

ATC Classification

R03AK06 - salmeterol and fluticasone ; Belongs to the class of adrenergics in combination with corticosteroids or other drugs, excluding anticholinergics. Used in the treatment of obstructive airway diseases.

Regulatory Classification

POM

Presentation/Packing

Form

Aroflo inhaler 125 mcg/25 mcg

Packing/Price

120 puff x 1's

Form

Aroflo inhaler 250 mcg/25 mcg

Packing/Price

120 puff x 1's

Aroflo

salmeterol + fluticasone

Manufacturer:

Aristopharma

Distributor:

KTZ